B-RAF is a therapeutic target in melanoma. (Record no. 14914173)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01471 a2200445 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514192334.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200409s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0950-9232 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/sj.onc.1207785 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Karasarides, Maria |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20040909 |
| 245 00 - TITLE STATEMENT | |
| Title | B-RAF is a therapeutic target in melanoma. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Oncogene |
| Date of publication, distribution, etc. | Aug 2004 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 6292-8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzenesulfonates |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Melanoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Niacinamide |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenylurea Compounds |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proto-Oncogene Proteins B-raf |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proto-Oncogene Proteins c-raf |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyridines |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sorafenib |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chiloeches, Antonio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hayward, Robert |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Niculescu-Duvaz, Dan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Scanlon, Ian |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Friedlos, Frank |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ogilvie, Lesley |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hedley, Douglas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martin, Jan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marshall, Christopher J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Springer, Caroline J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marais, Richard |
| 773 0# - HOST ITEM ENTRY | |
| Title | Oncogene |
| Related parts | vol. 23 |
| -- | no. 37 |
| -- | p. 6292-8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/sj.onc.1207785">https://doi.org/10.1038/sj.onc.1207785</a> |
| Public note | Available from publisher's website |
No items available.